5 Technologies Transforming How We Make Medicines at AbbVie’s Factory of the Future

Inside AbbVie’s Factory of the Future, AI, robotics and data analytics are creating tech-forward biotech jobs and careers – and getting medicines to patients faster.

Advancing the Science of Next-Generation Antibody-Drug Conjugates

See how we're advancing research of next generation of ADCs to tackle difficult-to-treat cancers.

Advancing Research in IBD: How Real World Evidence Helps to Uncover Gaps in Care

How real-world evidence is reshaping our understanding of IBD and driving innovative approaches to research and development.

Can We Find Cures Faster?

Learn how AbbVie researchers find and advance ideas that have the potential to cure.

From Brain Shuttles to Oral Peptides: 5 Technologies Advancing Research in Difficult-to-Treat Diseases

Discover a cohort of modalities our scientists are exploring that could help shape the future of medicine cancer, neuroscience and immune diseases.

Empowering Innovation Through the Health Equity Accelerator

Community-led organizations receive mentorship and funding to scale health equity solutions through the AbbVie Foundation's accelerator program.

Making medicine more accessible

3 ways AbbVie makes it easier for patients to get the medications their doctor has prescribed

Innovative Partnership Addresses Maternal Health Crisis

From coordinated support to practical services, this collaborative effort bridges gaps in care for pregnant people in underserved communities.

Beyond the Diagnosis

Meet a patient learning to navigate life with Parkinson’s, and a scientist dedicated to advancing research in the field.

Voices That Drive Innovation: AbbVie’s ERGs Make an Impact

From helping AbbVie advance patient outcomes to supporting veterans, see how employee groups are driving change.

5 ways our scientists work to deliver medicines 50% faster

When it comes to creating more time for patients with debilitating diseases, our goals are ambitious—and they need to be.

Care and Commitment: Celebrating AbbVie's 2025 Working Parents/Caregivers

This year, AbbVie is honoring two working caregivers who embody lives of service while caring for family members and building thriving careers.

Ovarian Cancer’s Impact Beyond the Body

Learn how ovarian cancer impacts the mental, emotional and social facets of women’s lives.

AbbVie’s Resilient Operations Network Helps Prevent Drug Shortages

See how AbbVie’s integrated manufacturing and data-driven forecasting help ensure patients get treatments without interruption.

AbbVie’s Work to Tackle the Economic Impact of Migraine in Latin America

Learn how AbbVie is partnering with the migraine community in Latin America to raise awareness of and help reduce the multi-billion-dollar global impact of migraine.

Meet Joe

New Yorker first. Cancer patient second.

Microsite Clinics Bring Free Health Care to Chicago’s Underserved

The AbbVie Foundation and CommunityHealth expand access to essential medical services in local communities.

How the Parkinson’s Disease Community and AbbVie are Shaping the Future of Care

Exploring new frontiers in Parkinson’s disease research.

One Veteran's Journey and AbbVie's Commitment to Mental Health Research

Stories like Josh Barker's drive us to innovate in mental health research

The promise of genetic medicine 

Discover how AbbVie is advancing research in genetic medicine. 

AbbVie’s 2024 Working Parents: Finding Purpose in Adversity

AbbVie’s 2024 Working Parents honorees not only overcame major obstacles—they channeled their experience into helping others.

Three ways AI is changing drug discovery at AbbVie

Explore how we harness the power of AI to find new treatments for diseases with large unmet need.

Elevating health care for all

See how AbbVie goes beyond the numbers to increase representation in clinical trials.

Transforming Cancer Care from the Inside Out

Discover how AbbVie’s supportive benefits are advancing cancer care for employees.

Magnified featuring Johanna Corbin

Explore Johanna’s incredible career journey from science to law.

Not good enough: behind the drive to give cancer patients more time

Two R&D leaders discuss AbbVie’s approach to develop solid tumor treatments

Recognizing the mental health impact of chronic skin disease

Elevating the standard of care by highlighting the mental, emotional and psychosocial impact of immune-mediated skin conditions.

Meet the ARCH, a time-saving tool for researchers focused on finding cures

An inside look at the creation of a search engine to help solve science’s toughest questions.

Magnified featuring Edrice Simmons

Explore the career journey of AbbVie’s VP of commercial oncology.

Working Parents 2023: Finding comfort in community

This year’s working parents share their stories of how they balance work, family and community involvement

Sharpening focus on eye diseases caused by diabetes

The experiences of these AbbVie leaders are aiming to elevate the standard of care for patients with diabetes and vision complications.

Breaking the rules of science to treat cancer

How AbbVie researchers toppled widely held scientific beliefs to create new possibilities for patients.

More than a stiff neck

Explore the impact of living with cervical dystonia.

Then and now: A renaissance in blood cancer treatment

See how scientists have nearly doubled some survival rates, and why we’re not done yet.

Cultivating change from within

Explore how AMPATH and the AbbVie Foundation are empowering expectant mothers in Kenya

What does it take to discover a new medicine?

In oncology, immunology, virology and beyond, researchers strive to turn science into breakthrough medicines. See how in AbbVie’s Discovery Files series.

Immunology’s Next Frontier 

How AbbVie is working to elevate the standards of care for patients with autoimmune diseases

Magnified featuring Nicholas Donoghoe

From studying medicine to leading teams building and launching AbbVie’s pipeline, see the path our R&D chief operating officer took to support patients all over the globe

Green initiatives helping AbbVie grow sustainably

In R&D, operations and beyond, employees do what’s good for patients, people and the planet

Little patients, big impact: Our approach to pediatric oncology

Two pediatric oncologists share their unique background and research approach at AbbVie to help find answers for the youngest patients.

Childhood cancer patients and their families find a home away from home

With AbbVie’s $50 million donation, St. Jude opens a new home-like environment where patient families can relax, recover and connect

Voices of AbbVie: Reflecting on a decade of impact

As we recognize 10 years as a company, what makes working at AbbVie unique? Global employees weigh in.

Making it migraine-friendly: Why we’re reimagining the workplace

See how AbbVie is creating a better workplace for people with migraine, the second-most disabling condition in the world.

Discovery Files: A Vision for Blood Cancer Patients

In this episode, veteran chemist Andy Souers rewinds to the “eureka” moment behind a cancer discovery and the 20-year journey to becoming a medicine. 

Three factors that drove the transformational integration of AbbVie, Allergan

Here’s how we brought together two diverse businesses and groups of people to build a new, stronger company

Why isn’t medicine one size fits all?

Precision medicine explained: Breaking down how this unique approach and commitment could fundamentally change how we treat disease.

AbbVie rebuilds North Chicago’s middle school

Built with AbbVie's $40 million donation, the new Neal Math and Science Academy now reflects the talent and potential of its students.

3 Lessons for Expanding Equity in Dermatology

Patients of color can face challenges when seeking care for skin conditions. See how we’re partnering with the dermatology community to help drive change.

AbbVie’s family benefits

Explore what makes AbbVie a family-friendly workplace

Inside The DREAM Initiative®

Why we’re reimagining beauty standards in the aesthetics industry

A history of discovery: Why we focus on challenging eye care diseases

Look at the science behind helping to prevent vision loss and impairment, a leading cause of disability that affects nearly 30% of the world’s population. 

Meet a director clearing the path for patient access

See how Eyoel Tsegay's work can make a difference for patients

AbbVie volunteers return to serving global communities through Week of Possibilities

With creativity and resilience, 15,000 employees go the distance to serve.

Unlocking the next level of protein degradation

What have we learned about degradomers?

Magnified featuring Darin Messina

From neuroscience to ophthalmology to bioengineering, see how our head of aesthetic science follows his passions to bring new opportunities to patients.

Ready, set, launch: AbbVie opens new facility in the Bay Area

In the birthplace of biotech, we’re continuing our investment in innovation.

Can unlocking one million genomes help us discover medicines faster?

With the most complete human genome sequenced yet, AbbVie’s Genomics Research Center aims to find out.

Progress toward treating neglected tropical diseases

How public-private partnerships are impacting global public health.

Our approach to data science and analytics

Get an inside look at our largest data initiative

Magnified featuring Jonathon Sedgwick

Meet our head of discovery science

Day in the Life: Government affairs director educates and empowers

What are the policies that will sustain scientific innovation? Philip Schwab is looking for answers.

They won’t back down

5 courageous voices on why investment in new medicines matters.

What are science-based targets?

It is the key for sustainable growth.

Magnified featuring Shuhong Zhang

Meet our development sciences VP

Magnified featuring Matt Widman

Meet a former chemist turned head of patient services

The story behind our $50 billion R&D investment

Discovering and developing new medicines is not easy. But it’s an aspiration that drives our science and is the foundation of this company.

Five reasons why small cell lung cancer is tough to treat

Researchers continue to bring into focus the reasons why small cell lung cancer is tough to treat and what can be done about it.

Day in the Life: Meet an engineer fostering diversity and inclusion within manufacturing

Carter has made it her mission to help women and underrepresented talent grow careers in STEM.

Connecting patients with care: 3 lessons learned during COVID-19

From cabs to counseling, see how innovative programs across the globe help address patient needs and ensure continuity of care.

Stronger together: A convergence of minds and data

Data convergence is anything but dull when you pair a veteran data scientist with a leader who connected human genome reading to clinical care.

Day in the Life: Creating impact with nonprofit partners

From managing major construction projects to infusing big flavors, see how associate director Krystal Bruno takes on the day.

Finding hope in a pandemic: A conversation with two hepatitis C experts

Views on how the pandemic has influenced the future of how we find and help people living with the disease.

Magnified featuring Sean McEwen

Get to know our VP of quality assurance

The math of migraine

One billion people impacted. Millions of workdays missed. Countless events skipped. The toll of migraine adds up. But so does progress in care.

Magnified featuring Linda Scarazzini

A closer look at the life experiences & career journeys that have shaped AbbVie’s leaders – like our head of pharmacovigilance & patient safety.

Precision Medicine – it’s not just for oncology anymore

Could precision medicine help immunology patients the way it has helped cancer patients?

Injecting hope, one vaccine at a time

From volunteering at a mass vaccination site to sponsoring a senior clinic, AbbVie helps the most vulnerable get vaccinated.

Navigating ulcerative colitis as a child

A diagnosis at 13 years old, Marisa Troy’s life and her aspirations were greatly impacted by her IBD.

The hardest-hit: How nonprofits rise to the challenge of COVID-19

Deep in the pandemic, community-based organizations share how they help vulnerable populations.

Inside the world of human factors engineers

Meet the team whose job is to solve problems before they exist

Life after stroke: Living with and researching spasticity

Prompt action is key to combat post-stroke spasticity. Researchers are trying to raise visibility of the condition to help people recognize it early.

Trapped in your own skin

Lessons from a lifelong journey with psoriasis

One person with psoriasis shares her journey — from childhood to working parent — and how her struggles with the disease have empowered her.

Shining a light on glaucoma and eye health

Helping patients get to a doctor sooner.

Living with the unknowns of Alzheimer’s disease

One patient faces the progression of Alzheimer’s disease through family, positivity and supporting research.

More than itchy skin: Breaking down the complexities of atopic dermatitis

Science is working to uncover the roots of this serious inflammatory disease.

Shedding light upon a misunderstood skin condition: Hidradenitis Suppurativa

After a long journey to diagnosis, one patient finds strength in advocating for herself and others.

How AbbVie is bringing antiviral expertise to the COVID-19 battle

At the first sign of the pandemic, AbbVie began evaluating ways to help, including accelerating discovery efforts and external collaborations.

How uterine fibroids feel to a patient…who’s also a doctor

An AbbVie researcher shares how her own struggles with uterine fibroids influenced her perspective as a doctor and scientist.

Ambassadors in action

Assembling the pieces of a blockbuster corporate culture.

Starting with a spark: An inside look at environmental sustainability

A global challenge proves that great ideas come from all corners of a company.

How medicinal chemists are creating new weapons against autoimmune diseases

Creative problem solving and data-driven science helps researchers illuminate a smarter path toward compounds that may address unmet patient needs.

The power of love in IBD

An invisible illness, Crohn’s disease impacts the patient and those closest to them. One patient shares how the love of her life helps her thrive every day.

Ensuring patients around the world get medicines during COVID-19

Facing unprecedented challenges, AbbVie’s resilience makes the difference in helping patients get the medicines they need.

Advancing a public health approach to patient safety

From administering vaccines in war zones to leading the FDA’s drug safety group, our patient safety leaders draw on their experiences to bring a focus on public health.

Advice from a scientist turned physician turned robot builder -- be curious

Why science is a team sport and failure isn’t all bad, says AbbVie’s new Chief Scientific Officer.

Navigating the hidden side of cancer

A cancer diagnosis can upend families’ budgets. Nonprofit Family Reach brings financial relief, and now they’re expanding to help even more families.

Why you can’t wait with rheumatoid arthritis

Why is it important for people to see a rheumatologist sooner rather than later?

Going inside prison walls to help eliminate hepatitis C

A former inmate returns to the prisons of Portugal to help those on the inside focus on hepatitis C care.

How patient voices are changing medicine

An AbbVie leader in patient-centered research helps us to hear and consider the patient voice.

Green chemistry

What's the impact from cleaner, faster chemical reactions?

The value of education: From a dim reality to a bright future

Communities In Schools helped a boy living without electricity grow into a man with a master’s degree. Now he’s paying it forward.

Synthetic control arm: the end of placebos?

Although randomization may always be the gold standard, Big Data is breathing new life into clinical trial design.

A molecular behavior chart: speeding up research with predictive analytics

Whether a molecule acts like a “lobster” or “crayfish” may predict its ability to one day become a medicine.

ChemBeads: Improving artificial intelligence through human ingenuity

Discovering a new medicine isn’t easy. When robots couldn’t help, three scientists found a way.

Rebuilding Puerto Rico

Learn how we're partnering to enhance resiliency and access to health care

Striving for patient centricity, down to the packaging

Understand the future of packaging and how it’s evolving to be more about the patient.

Decoding the Immune System’s Secrets

How do new medicines originate? Meet the team behind early development of AbbVie’s immunology treatments.

The blueprint of you: Unlocking the potential of whole genome sequencing

A genetic pioneer reveals what he learned from mapping his own genome.

Chasing the value of a walk down the aisle

Can you quantify the value of moments that matter? How patient experiences change the equation.

BTK protein: the good, the bad and the ugly

Bruton’s tyrosine kinase helps immune function, but its malfunction may lead to cancer and autoimmune diseases. Scientists are researching new approaches in both areas.

Hepatitis C: the mysterious virus that met its match

The virus that brims with unanswered questions never stopped researchers from solving a few of its mysteries over the last 25 years.

Real-world data rounds out value picture of drugs

Medical records and insurance claims data help companies, regulators, payers and physicians better understand how medicines perform in the real world.